MRSKF(MRSKF)
MRSKF
No analyst ratings available
No analyst price targets available for MRSKF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $574.77B | $615.21B | $644.04B | $630.58B |
| Low | $527.63B | $552.81B | $584.76B | $572.54B |
| High | $616.81B | $665.69B | $694.11B | $679.60B |
| EBITDA Avg | $68.22B | $83.69B | $92.69B | $103.30B |
| Low | $65.26B | $79.01B | $87.08B | $96.52B |
| High | $70.73B | $87.64B | $97.43B | $109.03B |
| EBIT Avg | $32.89B | $47.26B | $55.01B | $64.79B |
| Low | $29.93B | $42.58B | $49.40B | $58.01B |
| High | $35.39B | $51.22B | $59.75B | $70.52B |
| Net Income Avg | $16.24B | $25.67B | $30.75B | $37.17B |
| Low | $14.30B | $22.60B | $27.07B | $32.72B |
| High | $17.88B | $28.27B | $33.86B | $40.93B |
| EPS Avg | $114.93 | $181.67 | $217.64 | $263.05 |
| Low | $101.17 | $159.93 | $191.60 | $231.58 |
| High | $126.54 | $200.03 | $239.64 | $289.64 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $151.92B | $184.77B |
| Low | $147.64B | $178.27B |
| High | $156.20B | $191.27B |
| EBITDA Avg | $19.80B | $27.87B |
| Low | $19.46B | $27.20B |
| High | $20.13B | $28.54B |
| EBIT Avg | $10.41B | $18.34B |
| Low | $10.08B | $17.68B |
| High | $10.75B | $19.01B |
| Net Income Avg | $5.29B | $10.49B |
| Low | $5.07B | $10.05B |
| High | $5.51B | $10.93B |
| EPS Avg | $37.86 | $75.11 |
| Low | $36.28 | $71.98 |
| High | $39.43 | $78.23 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |